Cyient Limited Announces Resignation of Independent Director Ms. Matangi Gowrishankar

2 min read     Updated on 22 Jan 2026, 04:55 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Cyient Limited announced the resignation of Independent Director Ms. Matangi Gowrishankar (DIN: 01518137), effective January 22, 2026, citing personal reasons after nearly 7 years of service. She will cease to be Chairperson of the Leadership, Nomination and Remuneration Committee and step down from boards of material subsidiaries Cyient Inc. and Cyient Europe Limited. The company has complied with all regulatory disclosure requirements under SEBI regulations.

30626740

*this image is generated using AI for illustrative purposes only.

Cyient Limited has informed stock exchanges about the resignation of Ms. Matangi Gowrishankar as Independent Director, effective January 22, 2026. The company filed the intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Ms. Matangi Gowrishankar (DIN: 01518137) tendered her resignation as Independent Director citing personal reasons. The resignation became effective on January 22, 2026, following the close of the board meeting held on the same day.

Parameter: Details
Effective Date: January 22, 2026
Time of Occurrence: 15:45 hrs
Reason: Personal reasons
Service Period: Nearly 7 years

Impact on Board Composition

Following her resignation, Ms. Gowrishankar will cease to hold several key positions within the Cyient group:

  • Chairperson of Leadership, Nomination and Remuneration Committee of Cyient Limited
  • Board member of Cyient Inc. (material subsidiary)
  • Board member of Cyient Europe Limited (material subsidiary)

In her resignation letter dated January 21, 2026, Ms. Gowrishankar expressed gratitude for the opportunity to serve alongside distinguished industry leaders and described her tenure as a "rich and rewarding experience."

Other Board Positions

Ms. Gowrishankar currently serves as Independent Director on several other listed entities with various committee responsibilities:

Listed Entity: Committee Role
Greenlam Industries Limited Audit Committee Member
Nomination and Remuneration Committee Member
Corporate Social Responsibility Committee Chairperson
Akums Drugs and Pharmaceuticals Limited Audit Committee Member
Nomination and Remuneration Committee Chairperson
Risk Management Committee Member
Gujarat Pipavav Port Limited Audit Committee Member
Nomination and Remuneration Committee Chairperson
Stakeholder Relationship Committee Member
IDFC First Bank Limited Nomination and Remuneration Committee Chairperson
Stakeholder Relationship Committee Member
Corporate Social Responsibility Committee Member
Cohance Lifesciences Limited Nomination and Remuneration Committee Chairperson
Corporate Social Responsibility Committee Member

Regulatory Compliance

The company has fulfilled all disclosure requirements under SEBI regulations and stock exchange circulars. Ms. Gowrishankar confirmed in her resignation letter that there are no material reasons for her resignation other than the personal reasons mentioned. The resignation information has been made available on the company's website at www.cyient.com as per regulatory requirements.

Historical Stock Returns for Cyient

1 Day5 Days1 Month6 Months1 Year5 Years
-4.02%-1.44%-0.34%-8.92%-23.74%+67.94%

Cyient Q3FY26 Results: Net Profit Falls 24.9% to ₹918 Crores Amid Revenue Decline

2 min read     Updated on 22 Jan 2026, 04:48 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Cyient Limited's Q3FY26 results showed consolidated net profit declining 24.9% to ₹918 crores with revenue falling 4.0% to ₹18,485 crores. The quarter was impacted by ₹423 crores in exceptional charges due to new labour code implementation. While the DET segment grew 6.5%, DLM and Semiconductors segments declined significantly. The company also announced key corporate changes including director resignation and subsidiary closures.

30626323

*this image is generated using AI for illustrative purposes only.

Cyient Limited reported mixed Q3FY26 financial results for the quarter ended December 31, 2025, with consolidated net profit declining 24.9% year-on-year to ₹918 crores compared to ₹1,223 crores in the corresponding quarter of the previous fiscal year. The engineering and technology services company faced headwinds from revenue decline and exceptional charges during the quarter.

Financial Performance Overview

The company's consolidated revenue from contracts with customers decreased by 4.0% to ₹18,485 crores in Q3FY26 from ₹19,264 crores in Q3FY25. Total income, including other income, stood at ₹18,794 crores compared to ₹19,098 crores in the year-ago period.

Financial Metric Q3FY26 Q3FY25 Change (%)
Revenue from Operations ₹18,485 cr ₹19,264 cr -4.0%
Total Income ₹18,794 cr ₹19,098 cr -1.6%
Net Profit ₹918 cr ₹1,223 cr -24.9%
Profit Before Tax ₹1,393 cr ₹1,736 cr -19.8%

Nine-Month Performance

For the nine months ended December 31, 2025, consolidated revenue declined to ₹53,413 crores from ₹54,512 crores in the corresponding period of FY25, marking a 2.0% decrease. Net profit for the nine-month period reached ₹3,731 crores compared to ₹4,453 crores in the previous year, reflecting a 16.2% decline.

Exceptional Items Impact

The quarter's performance was significantly affected by exceptional charges totaling ₹423 crores. The primary component was a one-time increase in employee benefit provisions of ₹423 crores due to the implementation of India's New Labour Codes, which consolidated multiple existing labour laws into a unified framework effective November 21, 2025.

Segment-wise Performance

Cyient's business segments showed varied performance during Q3FY26:

Segment Q3FY26 Revenue Q3FY25 Revenue Change (%)
Digital, Engineering & Technology (DET) ₹14,883 cr ₹13,975 cr +6.5%
Design Led Manufacturing (DLM) ₹3,033 cr ₹4,443 cr -31.7%
Semiconductors ₹611 cr ₹824 cr -25.9%
Others ₹105 cr ₹94 cr +11.7%

The DET segment demonstrated resilience with 6.5% growth, while DLM and Semiconductors segments faced significant declines of 31.7% and 25.9% respectively.

Corporate Developments

The Board of Directors approved several strategic decisions during their meeting held on January 22, 2026:

Development Details
Director Resignation Ms. Matangi Gowrishankar resigned as Independent Director
Committee Reconstitution Leadership, Nomination and Remuneration Committee restructured
Norway Branch Closure of Norway branch operations
Subsidiary Closure Cyient Israel India Limited to be closed

Earnings Per Share

Basic earnings per share for Q3FY26 stood at ₹8.32 compared to ₹11.11 in Q3FY25. For the nine-month period, basic EPS was ₹33.82 against ₹40.48 in the corresponding period of the previous year.

Future Outlook Considerations

The company continues to monitor the finalization of Central and State rules related to the New Labour Codes and will incorporate appropriate accounting treatments based on future developments. Additionally, Cyient's subsidiary has entered into a definitive agreement to acquire majority stake in Kinetic Technologies for approximately ₹8,366 crores, subject to regulatory approvals and customary closing conditions.

Historical Stock Returns for Cyient

1 Day5 Days1 Month6 Months1 Year5 Years
-4.02%-1.44%-0.34%-8.92%-23.74%+67.94%

More News on Cyient

1 Year Returns:-23.74%